loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering VYTORIN

Menu
$ API Ref.Price (USD/KG) : 1,342Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8ALTHERA PHARMS

02 8ESPERION THERAPS INC

03 3ORGANON

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 10376470

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

02

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 9763885

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

03

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 9763885

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

04

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 10376470

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

05

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 10376470

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

06

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 9763885

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

07

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 10376470

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

08

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

EZETIMIBE; ROSUVASTATIN CALCIUM

US Patent Number : 9763885

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213072

Patent Use Code : U-3095

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-05-01

blank

09

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 11744816

Drug Substance Claim :

Drug Product Claim :

Application Number : 211617

Patent Use Code : U-3883

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-14

blank

10

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 10912751

Drug Substance Claim :

Drug Product Claim :

Application Number : 211617

Patent Use Code : U-3884

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-14

blank